Literature DB >> 11882395

Prognostic value of energy metabolism in patients with viral liver cirrhosis.

Masahiro Tajika1, Masahiko Kato, Hiromi Mohri, Yoshiyuki Miwa, Tomohiro Kato, Hiroo Ohnishi, Hisataka Moriwaki.   

Abstract

The effect of energy malnutrition on survival in patients with non-alcoholic viral liver cirrhosis has not been well defined. We characterized energy metabolism at study entrance and prospectively analyzed its effect on subsequent survival in cirrhotics. One hundred nine consecutive patients with viral liver cirrhosis and 22 healthy control subjects participated in the study. By indirect calorimetry after overnight bedrest and fasting, resting energy expenditure (REE) was measured and non-protein respiratory quotient (npRQ) was calculated. Survival of cirrhotics were followed for up to 8 y. Survival rate was estimated with the Kaplan-Meier method. REE at entrance was significantly higher than the predicted basal metabolic rate (BMR) in cirrhotics (P < 0.001). NpRQ was significantly lower in cirrhotics than in controls (P < 0.001). Survival rate was significantly lower in patients with low npRQ ( < 0.85) than in patients with scores above 0.85 (P < 0.01) and was significantly higher in normal metabolic patients (0.9 < REE/BMR < 1.1) than in hypometabolic (REE/BMR < 0.9) or hypermetabolic (1.1 < REE/BMR) patients (P < 0.05). The proportional hazards model showed that npRQ (relative risk = 0.0003, 95% confidence interval = 0.0000-0.0970), REE/BMR (0.0199, 0.0007-0.5652), prothrombin time, and ammonia were independent significant factors determining survival. Thus evaluation of energy metabolism can be used to predict survival in patients with viral liver cirrhosis.

Entities:  

Mesh:

Year:  2002        PMID: 11882395     DOI: 10.1016/s0899-9007(01)00754-7

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  54 in total

1.  Association of an Overhydrated State With the Liver Fibrosis and Prognosis of Cirrhotic Patients.

Authors:  Kyohei Kishino; Hirayuki Enomoto; Yoshihiro Shimono; Ei-Ichiro Moriwaki; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Nutritional assessment in liver cirrhosis.

Authors:  Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

4.  Long-term nutritional assessment and quality of life in patients with cirrhosis taking a late evening snack.

Authors:  Hiroaki Okuda; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

5.  Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis.

Authors:  Fátima A F Figueiredo; Renata M Perez; Márcia M Freitas; Mário Kondo
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 6.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

7.  Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.

Authors:  Soichi Iritani; Kenji Imai; Koji Takai; Tatsunori Hanai; Takayasu Ideta; Tsuneyuki Miyazaki; Atsushi Suetsugu; Makoto Shiraki; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2014-05-10       Impact factor: 7.527

8.  Resting energy expenditure and glucose, protein and fat oxidation in severe chronic virus hepatitis B patients.

Authors:  Chun-Lei Fan; Yan-Jing Wu; Zhong-Ping Duan; Bin Zhang; Pei-Ling Dong; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 9.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 10.  Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Authors:  Taro Takami; Takahiro Yamasaki; Issei Saeki; Toshihiko Matsumoto; Yutaka Suehiro; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.